PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24793882-0	2014	Ruthenium(II) complexes as apoptosis inducers by stabilizing c-myc G-quadruplex DNA.	Ruthenium(II)	0-13	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	61-66	
28888786-0	2017	Microwave-assisted synthesis of ruthenium(II) complexes with alkynes as potential inhibitor by selectively recognizing c-myc G-quadruplex DNA.	Ruthenium(II)	32-45	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	119-124	
28888786-8	2017	Thus, these ruthenium(II) complexes can be developed as potential inhibitors in chemotherapy through their binding and stabilization of c-myc G-quadruplex DNA.	Ruthenium(II)	12-25	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	136-141	
25988535-2	2015	It was found that these ruthenium(II) complexes exhibited considerable in vitro anticancer activities and that they were the effective stabilizers of telomeric and G-quadruplex-DNA (G4-DNA) in promoter of c-myc, which acted as a telomerase inhibitor targeting G4-DNA and induced cell senescence and apoptosis.	Ruthenium(II)	24-37	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	205-210	
24793882-6	2014	In a word, this type of ruthenium(II) complexes can act as potential apoptosis inducers with low toxicity in clinic by stabilizing c-myc G4 DNA.	Ruthenium(II)	24-37	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	131-136